Case Report
Copyright ©The Author(s) 2023.
World J Clin Cases. Jun 16, 2023; 11(17): 4152-4158
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4152
Figure 1
Figure 1 Serial chest radiographs images in HD 1, HD 9, HD 12, and 9 mo after discharge. A: Chest radiograph shows diffuse bilateral consolidations with a small amount of bilateral pleural effusions; B: Follow-up chest radiograph with antibiotic treatment shows a slight decrease in the extent of bilateral lung parenchymal; C: Follow-up chest radiograph after steroid pulse therapy shows a decrease in the extent of bilateral consolidations with residual opacities and suspicious bronchial dilation; D: Follow-up chest radiograph after discharge shows near resolution of bilateral lung disease with no evidence of reticular opacities.
Figure 2
Figure 2 Serial chest computed tomography images in time of coronavirus disease 2019, HD 2, HD 12, and 9 mo after discharge. A and B: Chest computed tomography (CT) scans performed at the time of coronavirus disease 2019 (COVID-19) (6 wk prior to admission) show peribronchovascular distributed consolidations in both lungs, with greater extent in left lung; this is consistent with COVID-19 pneumonia; C and D: Chest CT scans performed on admission show diffuse ground-glass opacities and patchy consolidations in both lungs and small to moderate amount of bilateral pleural effusions; E and F: Follow-up low-dose chest CT scans after steroid pulse therapy show decreased extent and density of bilateral parenchymal opacifications and more progressed bronchial dilatation; G and H: Follow-up chest CT scans after discharge show almost resolution of bilateral lung disease with mild residual ground-glass opacities in peripheral lungs.